CN104188978B - 闭花木酮的o-(四氢吡咯基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 - Google Patents
闭花木酮的o-(四氢吡咯基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 Download PDFInfo
- Publication number
- CN104188978B CN104188978B CN201410375213.2A CN201410375213A CN104188978B CN 104188978 B CN104188978 B CN 104188978B CN 201410375213 A CN201410375213 A CN 201410375213A CN 104188978 B CN104188978 B CN 104188978B
- Authority
- CN
- China
- Prior art keywords
- cleistanone
- nafoxidine base
- ethyl derivative
- kidney
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410375213.2A CN104188978B (zh) | 2014-07-31 | 2014-07-31 | 闭花木酮的o-(四氢吡咯基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410375213.2A CN104188978B (zh) | 2014-07-31 | 2014-07-31 | 闭花木酮的o-(四氢吡咯基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104188978A CN104188978A (zh) | 2014-12-10 |
CN104188978B true CN104188978B (zh) | 2016-08-31 |
Family
ID=52074455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410375213.2A Expired - Fee Related CN104188978B (zh) | 2014-07-31 | 2014-07-31 | 闭花木酮的o-(四氢吡咯基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104188978B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758298A (zh) * | 2015-04-15 | 2015-07-08 | 南京大学 | 闭花木酮的o-(1h-四氮唑基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 |
CN104840472A (zh) * | 2015-04-29 | 2015-08-19 | 南京广康协生物医药技术有限公司 | 闭花木酮的o-(苯并咪唑基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 |
CN104887669A (zh) * | 2015-05-12 | 2015-09-09 | 南京广康协生物医药技术有限公司 | Daphmalenine A衍生物在制备治疗或预防肾纤维化药物中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100551379C (zh) * | 2006-03-06 | 2009-10-21 | 上海医药工业研究院 | 积雪苷在制备预防或治疗肾脏纤维化的药物中的应用 |
US20150246087A1 (en) * | 2012-06-11 | 2015-09-03 | Regenera Pharma Ltd. | Extracts and therapeutic uses thereof |
-
2014
- 2014-07-31 CN CN201410375213.2A patent/CN104188978B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104188978A (zh) | 2014-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104188978B (zh) | 闭花木酮的o-(四氢吡咯基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 | |
CN104147019B (zh) | 闭花木酮的o-(四氢吡咯基)乙基衍生物在制备预防或治疗胰腺纤维化药物中的应用 | |
CN104095860A (zh) | 闭花木酮Cleistanone的O-(四氢吡咯基)乙基衍生物在制备抗炎药物中的应用 | |
CN104188980B (zh) | 闭花木酮Cleistanone的O-(吗啉基)乙基衍生物、制备方法及其用途 | |
CN104758298A (zh) | 闭花木酮的o-(1h-四氮唑基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 | |
CN104095856B (zh) | 闭花木酮Cleistanone的二乙胺衍生物在制备抗急性肾衰药物中的应用 | |
CN104840472A (zh) | 闭花木酮的o-(苯并咪唑基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 | |
CN104434929B (zh) | 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗急性肾衰药物中的应用 | |
CN105902550A (zh) | Virosaine A的四氢吡咯基和吗啉基衍生物的组合物在治疗或预防肾纤维化药物中的应用 | |
CN104825466A (zh) | 闭花木酮的o-(苯并咪唑基)乙基衍生物在制备预防或治疗胰腺纤维化药物中的应用 | |
CN105412117A (zh) | 一种组合物及其在治疗或预防肾纤维化药物中的应用 | |
CN105326842A (zh) | 组合物及其在治疗或预防肾纤维化药物中的应用 | |
CN105232512A (zh) | 一种组合物及其在治疗或预防肾纤维化药物中的应用 | |
CN106074535A (zh) | 阿掏比克酸三唑基与1h‑四氮唑基衍生物的组合物用于制备防治肾纤维化药物 | |
CN106727466A (zh) | Atropurpuran的衍生物组合物用于防治肾纤维化 | |
CN105078986A (zh) | 组合物89083001030568及其在治疗或预防肾纤维化药物中的应用 | |
CN106727570A (zh) | Psiguadial A的哌嗪基和1H‑四氮唑基衍生物组合物用于防治肾纤维化 | |
CN106727532A (zh) | Psiguadial A的苯并咪唑基和二氯乙胺基衍生物组合物用于防治肾纤维化 | |
CN106727520A (zh) | Atropurpuran的咪唑基和二氯乙胺基衍生物组合物用于防治肾纤维化 | |
CN106727527A (zh) | Psiguadial A的咪唑基和二羟乙胺基衍生物组合物用于防治肾纤维化 | |
CN106265655A (zh) | Schiglautone A的衍生物组合物在治疗或预防肾纤维化药物中的应用 | |
CN106109453A (zh) | Artalbic acid的衍生物的组合物用于制备防治肾纤维化药物 | |
CN106074524A (zh) | Schiglautone A衍生物的组合物用于制备防治肾纤维化药物 | |
CN104887669A (zh) | Daphmalenine A衍生物在制备治疗或预防肾纤维化药物中的应用 | |
CN104873507A (zh) | Daphmalenine A的O-(二乙胺基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Qinmi Inventor after: Zhang Dawei Inventor after: Sun Daoxian Inventor after: Song Zhenfan Inventor before: Jiang Chunping Inventor before: Huang Rong Inventor before: Wu Junhua |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160803 Address after: Department of Radiology No. 4 people's Hospital of Jimo City Jianmin street Jimo city Shandong province 266200 city of Qingdao Applicant after: Yu Qinmi Address before: Metro Technology Building No. 69 Olympic Avenue in Jianye District of Nanjing city in Jiangsu province 210019 01 5 storey buildings Applicant before: Nanjing Guangkangxie Biomedical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160831 Termination date: 20170731 |
|
CF01 | Termination of patent right due to non-payment of annual fee |